CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands	Total	Stockholders’ Equity (Deficit)	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive (Loss)	Treasury stock, at cost	Non-controlling Interest
Balance at Dec. 31, 2023	$ 80,096	$ 78,734	$ 12	$ 837,416	$ (760,227)	$ 2,198	$ (665)	$ 1,362
Balance (in Shares) at Dec. 31, 2023			111,132,222
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of RSUs	1	1	$ 1
Vesting of RSUs (in Shares)			2,456,403
Issuance of RSAs (in Shares)			269,453
Exercise of common stock options	3,787	3,787		3,787
Exercise of common stock options (in Shares)			1,381,143
Exercise of common warrants	31,387	31,387	$ 1	31,386
Exercise of common warrants (in Shares)			14,531,193
Stock-based compensation expense	14,040	14,040		14,040
Interest payment through issuance of shares of common stock	3,842	3,842		3,842
Interest payment through issuance of shares of common stock (in Shares)			352,171
Redemption of non-controlling interests	67	1,429		1,429				(1,362)
Redemption of non-controlling interests (in Shares)			397,037
Reclassification of warrant liability to common stock warrants	11,523	11,523		11,523
Shares of Common Stock received from settlement of employee receivables	(28)	(28)					(28)
Shares of Common Stock received from settlement of employee receivables (in Shares)			(3,016)
Shares of Common Stock issued to settle Asset Purchase Agreement liability	8,818	8,818		8,818
Shares of Common Stock issued to settle Asset Purchase Agreement liability (in Shares)			620,106
Net loss	(101,879)	(101,879)			(101,879)
Foreign currency translation adjustment	(1,533)	(1,533)				(1,533)
Balance at Dec. 31, 2024	50,121	50,121	$ 14	912,241	(862,106)	665	(693)
Balance (in Shares) at Dec. 31, 2024			131,136,712
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of RSUs	1	1	$ 1
Vesting of RSUs (in Shares)			1,902,059
Issuance of RSAs (in Shares)			120,265
Exercise of common stock options	$ 1,957	1,957		1,957
Exercise of common stock options (in Shares)	621,000		621,226
Exercise of common warrants	$ 858	858		858
Exercise of common warrants (in Shares)			397,187
Stock-based compensation expense	16,294	16,294		16,294
Issuance of Common Warrants	9,006	9,006		9,006
Reclassification of warrant liability to common stock warrants	1,241	1,241		1,241
Shares of Common Stock issued to settle Asset Purchase Agreement liability	20,394	20,394		20,394
Shares of Common Stock issued to settle Asset Purchase Agreement liability (in Shares)			1,194,820
Net loss	(189,253)	(189,253)			(189,253)
Foreign currency translation adjustment	3,146	3,146				3,146
Balance at Dec. 31, 2025	$ (86,235)	$ (86,235)	$ 15	$ 961,991	$ (1,051,359)	$ 3,811	$ (693)
Balance (in Shares) at Dec. 31, 2025			135,372,269